HSA Singapore's Proposed Mandatory Health Supplement Notification: What Brands Need to Know

Singapore's Health Sciences Authority (HSA) has proposed a significant change to how health supplements are regulated. If adopted, manufacturers and importers will be required to notify HSA before placing health supplements on the Singapore market - a shift from today's largely post-market oversight model.

While the proposed framework is still under public consultation and is expected to be implemented no earlier than 2028, the direction is clear: regulators are moving towards greater product transparency, traceability, and accountability.

For health supplement brands and manufacturers, this is more than a regulatory update. It signals a broader shift in how compliance and consumer trust are becoming increasingly important competitive advantages.

Why this matters beyond compliance

For many businesses, regulatory compliance has traditionally been viewed as a requirement to satisfy regulators before launching a product.

Today, it's becoming much more than that.

Consumers are paying closer attention to ingredient transparency, product claims, and brand credibility. At the same time, regulators are strengthening oversight of the rapidly growing health supplement industry.

According to HSA, the proposed framework aims to:

• Improve consumer protection

• Enhance traceability of health supplements

• Strengthen post-market surveillance

• Enable faster regulatory action when safety issues arise

For brands, this reflects a growing expectation that product safety and regulatory compliance should be built into the business—not addressed only after products reach the market.

What is HSA proposing?

Currently, notification of health supplements to HSA is voluntary, with companies responsible for ensuring their own compliance while HSA conducts post-market surveillance.

Under the proposed framework, HSA intends to introduce:

• Mandatory notification before health supplements are supplied in Singapore

• Requirements to maintain supporting product documentation

• Obligations to report serious adverse events

• Improved product traceability

• Enhanced enforcement powers under the Health Products Act

Importantly, this is not a pharmaceutical-style product registration system. HSA has stated that the proposal is intended to strengthen oversight while maintaining a proportionate, risk-based approach for lower-risk health supplements.

What does this mean for brands and manufacturers?

Although implementation is still some time away, businesses should see this as an opportunity to prepare.

Compliance needs to happen earlier

Many compliance issues are only identified after formulations are finalised, packaging has been printed, and launch dates have been committed.

Discovering a non-compliant ingredient, unsupported claim, or labelling issue at that stage can lead to costly redesigns and delayed launches. As regulatory expectations evolve, compliance is becoming an earlier and more integrated part of product development rather than a final check before market entry.

Documentation becomes more important

Mandatory notification also places greater emphasis on maintaining accurate product documentation.

Brands should ensure they have organised records for:

• Ingredient specifications

• Supplier documentation

• Certificates of analysis

• Product formulations

• Supporting safety information

Good documentation not only supports compliance but also enables faster responses to regulators, distributors, and retail partners when needed.

Consumer trust becomes a competitive advantage

Perhaps the biggest shift is not regulatory - it's commercial.

Consumers increasingly expect brands to demonstrate that their products are safe, accurately labelled, and responsibly developed.

Retailers are also becoming more selective, recognising that regulatory issues can affect their own reputation.

Brands that invest in robust compliance processes are better positioned to build trust with both consumers and business partners.

Why brands shouldn't wait until 2028

Although implementation is expected no earlier than 2028, building strong compliance processes takes time.

Brands can start preparing today by:

• Reviewing formulations and product claims

• Organising regulatory documentation

• Validating labels against current requirements

• Assessing products that may require additional supporting evidence

• Establishing processes to monitor future regulatory changes

Preparing early not only reduces future compliance risk but can also improve operational efficiency today.

Technology will play an increasingly important role

As companies expand across multiple products and markets, managing compliance through spreadsheets, email chains, and manual research becomes increasingly difficult.

Digital compliance platforms help brands centralise documentation, assess products against market-specific requirements, and stay informed as regulations evolve.

Rather than reacting to regulatory changes, businesses can build compliance into their product development process—reducing risk while accelerating market readiness.

Looking ahead

HSA's proposed mandatory notification framework represents more than a regulatory update.

It reflects a broader shift towards greater transparency, stronger accountability, and higher expectations for consumer product safety.

Whether the proposal changes during consultation or not, the message for brands is clear: compliance is becoming an increasingly important part of building consumer trust and protecting brand reputation.

Businesses that prepare early won't just be ready for future regulations, they'll be better positioned to bring products to market with confidence.

Sources

• Health Sciences Authority (HSA). Public Consultation on the Proposed Regulatory Framework for Complementary Health Products.

• Health Sciences Authority (HSA). Health Supplement Regulations.

• NutraIngredients Asia. "Singapore regulator proposes mandatory health supplements notification."